Company: MLTX
Filing Date: 2025-11-05
Form Type: 8-K
Source: 0001213900-25-106723
Chunk: 0

Company: MoonLake Immunotherapeutics
Filing Date: 2025-11-05
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01. Entry into a Material Definitive Agreement.

On November 5, 2025,
MoonLake Immunotherapeutics (the “ Company”) entered into an underwriting agreement (“ Underwriting
Agreement”) with Leerink Partners LLC as the underwriter named therein (the “ Underwriter”), to issue and sell
7,142,857 Class A ordinary shares, par value $0.0001 per share (the “ Shares”), at an offering price of $10.50 per share
(the “ Offering”).

The gross proceeds from the Offering are expected
to be $75 million before deducting underwriting discounts and offering expenses.

The Shares described
above were offered pursuant to a shelf registration statement on Form S-3 (File No. 333-274286), which became effective on September
11, 2023. A prospectus supplement dated November 5, 2025 relating to and describing the terms of the Offering was filed with the
U. S. Securities and Exchange Commission on November 5, 2025. The Offering is expected to close on November 6, 2025, subject to the
satisfaction of customary closing conditions.

In the Underwriting Agreement, the Company agreed
to indemnify the Underwriter against certain liabilities, including liabilities under the Securities Act of 1933, as amended, or to contribute
payments that the Underwriter may be required to make because of such liabilities.

A copy of the Underwriting Agreement is filed
as Exhibit 1.1 and is incorporated herein by reference. The foregoing description of the Underwriting Agreement does not purport to be
complete and is qualified in its entirety by reference to such exhibit.

Walkers (Cayman) LLP,
Cayman counsel to the Company, has issued an opinion to the Company, dated November 5, 2025, regarding the validity of the issuance
and sale of the Shares in the Offering. A copy of the opinion is filed herewith as Exhibit 5.1.

Item 9.01. Financial Statements and Exhibits.